INOVIO PHARMACEUTICALS INC shareholders Q3 2023

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

INOVIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GTS SECURITIES LLC 14,725$5,7280.00%
HighTower Advisors, LLC 34,423$13,0000.00%
HRT FINANCIAL LP 19,313$70.00%
TWO SIGMA ADVISERS, LP 13,200$5,1350.00%
Daiwa Securities Group Inc. 720$00.00%
PATHSTONE FAMILY OFFICE, LLC 148,392$57,7240.00%
Highlander Capital Management, LLC 50$00.00%
EverSource Wealth Advisors, LLC 1,244$4840.00%
Bogart Wealth, LLC 5$20.00%
Steward Partners Investment Advisory, LLC 57$220.00%
IFG Advisory, LLC 10,000$3,8900.00%
Qube Research & Technologies Ltd 58,260$22,6630.00%
Larson Financial Group LLC 100$390.00%
GPS Wealth Strategies Group, LLC 50$190.00%
Financial Gravity Asset Management, Inc. 17$70.00%
Apollon Wealth Management, LLC 10,000$3,8900.00%
CARY STREET PARTNERS INVESTMENT ADVISORY LLC 500$1950.00%
Global Wealth Management Investment Advisory, Inc. 250$970.00%
Banque Cantonale Vaudoise 2$00.00%
Tower Research Capital LLC (TRC) 36,760$14,3000.00%
External links

This page lists INOVIO PHARMACEUTICALS INC's shareholders in Q3 2023. To view INOVIO PHARMACEUTICALS INC's shareholder history, click here.